chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Ureteral stent insertion, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Moderna Dose 1 7/15/21 Moderna Dose 2 8/17/21 COVID Positive 10/13/21 COVID Positive 10/15/21  10/15/21: -Patient is a 44yo female with medical history of Asthma, allergic rhinitis  , Anxiety/Depression , GERD , DMT2 ,HLD,  DVT/ PE , Iron deficiency anemia, Obesity, Former smoker.  -She is a transfer from ER for severe asthma exacerbation requiring intubation and sedation .  -She recieved 10mg IV decadron, duoneb treatment x 2, total 4g magnesium  -ER provider consulted pulmonary  -Latest VBG with PH 7.43, pCO2 39, pO2 41 . Otherwise rest of labs unremarkable  -Vitals remarkable for systolic BP 130-140 and diastolic BP 80s-100, HR 96-100, RR 20s, currently saturating > 95% on 60% FIO , tidal volume 400, PEEP 7 .  10/23/21: As noted patient was admitted for severe asthma exacerbation requiring intubation, was admitted to ICU started on Solu-Medrol, nebs, antibiotics pulmonary/critical care was consulted.  Was able to be extubated on 10/18 moved to medical floor, steroids titrated down, breathing treatments spaced out.  Patient was eventually weaned off oxygen to room air.  Will be discharged on a prednisone taper and complete course of empiric Levaquin.  Was also noted to be COVID-19 positive not completed course of remdesivir, has been vaccinated with Madonna vaccine on August 2021. During course of admission also was noted to have mild hydronephrosis some back/flank discomfort.  Urology evaluated patient cystoscopy with right ureteral stent placement on tele on/21, Flomax.  Acute symptoms resolved, stone has not passed yet however patient will follow-up with Urology on disposition for longitudinal management.  Otherwise patient on room air not requiring any supplemental oxygen on O2 walk.  All ED and RTC precautions have been provided to patient, endorses understanding and agreement with plan as outlined.  COVID precautions have also been provided to patient along with quarantine.  Small amount of analgesics for 2 days provided status post stent placement.  Was initially managed on heparin infusion bridge back to Coumadin INR therapeutic prior to disposition.  Will check INR in lab work on discharge follow-up with PCP.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was hospitalized with COVID after receiving COVID vaccine.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Blood gases, Blood pH normal, Blood potassium increased, COVID-19, Chest X-ray normal
Clinical narrative: COVID vaccine Breakthrough Case  Pfizer Dose 1 3/27/21 (lot not listed in system) Pfizer Dose 2 4/17/21 (lot not listed in system) COVID Positive 10/14/21  10/14/21: Patient is 56-year-old female with no significant past medical history except tobacco abuse.  She presented to the emergency room with complaint of worsening shortness of breath cough and wheezing.  Patient reported that she has been having progressively worsening exertional dyspnea and chest tightness for which she was being worked up by her PCP.  Multiple workups including chest x-ray and echocardiogram were unremarkable.  She came to the emergency room today for worsening of shortness of breath, cough and wheezing for the past 2 days.  Patient reported that since 2 months ago, she has been having exertional dyspnea and chest tightness.  She reported heaviness in retrosternal area mainly precipitated by exertion.  She reported cough productive of scanty sputum which she says has been there for long time as she is a chronic smoker. She denied worsening of cough.  No fever chills or rigors. Since 2 days ago, she has been having worsening of dyspnea and chest tightness.  No fever chills or rigors.  No wheezing.  No nausea vomiting or abdominal pain.  Patient denied family or personal history of cardiac illness.  She has been smoking up to 1 and half pack of cigarettes for the past 4 years.  She denied use of alcohol.  Patient is fully vaccinated for COVID-19.  At the emergency room, she was noted to be hypoxic saturating 87% on room air and requiring up to 2 L of oxygen to maintain saturation.  She was hypertensive with blood pressure of 145/98.  She was afebrile with no tachycardia.  ABG revealed CO2 retention with pCO2 at 58 with normal pH.  Other significant lab findings were hyperkalemia at 5.3 which resolved, and leukopenia with WBC count at 4000. Rapid COVID-19 antigen test was positive. Chest x-ray did not show any infiltrates.  D-dimer was negative.  EKG was unremarkable.  10/18/21: Nebulizer treatments  P.o. prednisone course  P.o. Levaquin course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient will need pulmonary function testing as outpatient  COVID-19 precautions per CDC guidelines  Patient qualified for home oxygen, 1 L via nasal cannula with activity  Patient agrees with plan of care
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Dyspnoea exertional, Echocardiogram normal, Electrocardiogram normal
Clinical narrative: COVID vaccine Breakthrough Case  Pfizer Dose 1 3/27/21 (lot not listed in system) Pfizer Dose 2 4/17/21 (lot not listed in system) COVID Positive 10/14/21  10/14/21: Patient is 56-year-old female with no significant past medical history except tobacco abuse.  She presented to the emergency room with complaint of worsening shortness of breath cough and wheezing.  Patient reported that she has been having progressively worsening exertional dyspnea and chest tightness for which she was being worked up by her PCP.  Multiple workups including chest x-ray and echocardiogram were unremarkable.  She came to the emergency room today for worsening of shortness of breath, cough and wheezing for the past 2 days.  Patient reported that since 2 months ago, she has been having exertional dyspnea and chest tightness.  She reported heaviness in retrosternal area mainly precipitated by exertion.  She reported cough productive of scanty sputum which she says has been there for long time as she is a chronic smoker. She denied worsening of cough.  No fever chills or rigors. Since 2 days ago, she has been having worsening of dyspnea and chest tightness.  No fever chills or rigors.  No wheezing.  No nausea vomiting or abdominal pain.  Patient denied family or personal history of cardiac illness.  She has been smoking up to 1 and half pack of cigarettes for the past 4 years.  She denied use of alcohol.  Patient is fully vaccinated for COVID-19.  At the emergency room, she was noted to be hypoxic saturating 87% on room air and requiring up to 2 L of oxygen to maintain saturation.  She was hypertensive with blood pressure of 145/98.  She was afebrile with no tachycardia.  ABG revealed CO2 retention with pCO2 at 58 with normal pH.  Other significant lab findings were hyperkalemia at 5.3 which resolved, and leukopenia with WBC count at 4000. Rapid COVID-19 antigen test was positive. Chest x-ray did not show any infiltrates.  D-dimer was negative.  EKG was unremarkable.  10/18/21: Nebulizer treatments  P.o. prednisone course  P.o. Levaquin course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient will need pulmonary function testing as outpatient  COVID-19 precautions per CDC guidelines  Patient qualified for home oxygen, 1 L via nasal cannula with activity  Patient agrees with plan of care
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer normal, Hypercapnia, Hyperkalaemia, Hypertension, Hypoxia
Clinical narrative: COVID vaccine Breakthrough Case  Pfizer Dose 1 3/27/21 (lot not listed in system) Pfizer Dose 2 4/17/21 (lot not listed in system) COVID Positive 10/14/21  10/14/21: Patient is 56-year-old female with no significant past medical history except tobacco abuse.  She presented to the emergency room with complaint of worsening shortness of breath cough and wheezing.  Patient reported that she has been having progressively worsening exertional dyspnea and chest tightness for which she was being worked up by her PCP.  Multiple workups including chest x-ray and echocardiogram were unremarkable.  She came to the emergency room today for worsening of shortness of breath, cough and wheezing for the past 2 days.  Patient reported that since 2 months ago, she has been having exertional dyspnea and chest tightness.  She reported heaviness in retrosternal area mainly precipitated by exertion.  She reported cough productive of scanty sputum which she says has been there for long time as she is a chronic smoker. She denied worsening of cough.  No fever chills or rigors. Since 2 days ago, she has been having worsening of dyspnea and chest tightness.  No fever chills or rigors.  No wheezing.  No nausea vomiting or abdominal pain.  Patient denied family or personal history of cardiac illness.  She has been smoking up to 1 and half pack of cigarettes for the past 4 years.  She denied use of alcohol.  Patient is fully vaccinated for COVID-19.  At the emergency room, she was noted to be hypoxic saturating 87% on room air and requiring up to 2 L of oxygen to maintain saturation.  She was hypertensive with blood pressure of 145/98.  She was afebrile with no tachycardia.  ABG revealed CO2 retention with pCO2 at 58 with normal pH.  Other significant lab findings were hyperkalemia at 5.3 which resolved, and leukopenia with WBC count at 4000. Rapid COVID-19 antigen test was positive. Chest x-ray did not show any infiltrates.  D-dimer was negative.  EKG was unremarkable.  10/18/21: Nebulizer treatments  P.o. prednisone course  P.o. Levaquin course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient will need pulmonary function testing as outpatient  COVID-19 precautions per CDC guidelines  Patient qualified for home oxygen, 1 L via nasal cannula with activity  Patient agrees with plan of care
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Leukopenia, PCO2 increased, Productive cough, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine Breakthrough Case  Pfizer Dose 1 3/27/21 (lot not listed in system) Pfizer Dose 2 4/17/21 (lot not listed in system) COVID Positive 10/14/21  10/14/21: Patient is 56-year-old female with no significant past medical history except tobacco abuse.  She presented to the emergency room with complaint of worsening shortness of breath cough and wheezing.  Patient reported that she has been having progressively worsening exertional dyspnea and chest tightness for which she was being worked up by her PCP.  Multiple workups including chest x-ray and echocardiogram were unremarkable.  She came to the emergency room today for worsening of shortness of breath, cough and wheezing for the past 2 days.  Patient reported that since 2 months ago, she has been having exertional dyspnea and chest tightness.  She reported heaviness in retrosternal area mainly precipitated by exertion.  She reported cough productive of scanty sputum which she says has been there for long time as she is a chronic smoker. She denied worsening of cough.  No fever chills or rigors. Since 2 days ago, she has been having worsening of dyspnea and chest tightness.  No fever chills or rigors.  No wheezing.  No nausea vomiting or abdominal pain.  Patient denied family or personal history of cardiac illness.  She has been smoking up to 1 and half pack of cigarettes for the past 4 years.  She denied use of alcohol.  Patient is fully vaccinated for COVID-19.  At the emergency room, she was noted to be hypoxic saturating 87% on room air and requiring up to 2 L of oxygen to maintain saturation.  She was hypertensive with blood pressure of 145/98.  She was afebrile with no tachycardia.  ABG revealed CO2 retention with pCO2 at 58 with normal pH.  Other significant lab findings were hyperkalemia at 5.3 which resolved, and leukopenia with WBC count at 4000. Rapid COVID-19 antigen test was positive. Chest x-ray did not show any infiltrates.  D-dimer was negative.  EKG was unremarkable.  10/18/21: Nebulizer treatments  P.o. prednisone course  P.o. Levaquin course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient will need pulmonary function testing as outpatient  COVID-19 precautions per CDC guidelines  Patient qualified for home oxygen, 1 L via nasal cannula with activity  Patient agrees with plan of care
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing, White blood cell count decreased
Clinical narrative: COVID vaccine Breakthrough Case  Pfizer Dose 1 3/27/21 (lot not listed in system) Pfizer Dose 2 4/17/21 (lot not listed in system) COVID Positive 10/14/21  10/14/21: Patient is 56-year-old female with no significant past medical history except tobacco abuse.  She presented to the emergency room with complaint of worsening shortness of breath cough and wheezing.  Patient reported that she has been having progressively worsening exertional dyspnea and chest tightness for which she was being worked up by her PCP.  Multiple workups including chest x-ray and echocardiogram were unremarkable.  She came to the emergency room today for worsening of shortness of breath, cough and wheezing for the past 2 days.  Patient reported that since 2 months ago, she has been having exertional dyspnea and chest tightness.  She reported heaviness in retrosternal area mainly precipitated by exertion.  She reported cough productive of scanty sputum which she says has been there for long time as she is a chronic smoker. She denied worsening of cough.  No fever chills or rigors. Since 2 days ago, she has been having worsening of dyspnea and chest tightness.  No fever chills or rigors.  No wheezing.  No nausea vomiting or abdominal pain.  Patient denied family or personal history of cardiac illness.  She has been smoking up to 1 and half pack of cigarettes for the past 4 years.  She denied use of alcohol.  Patient is fully vaccinated for COVID-19.  At the emergency room, she was noted to be hypoxic saturating 87% on room air and requiring up to 2 L of oxygen to maintain saturation.  She was hypertensive with blood pressure of 145/98.  She was afebrile with no tachycardia.  ABG revealed CO2 retention with pCO2 at 58 with normal pH.  Other significant lab findings were hyperkalemia at 5.3 which resolved, and leukopenia with WBC count at 4000. Rapid COVID-19 antigen test was positive. Chest x-ray did not show any infiltrates.  D-dimer was negative.  EKG was unremarkable.  10/18/21: Nebulizer treatments  P.o. prednisone course  P.o. Levaquin course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient will need pulmonary function testing as outpatient  COVID-19 precautions per CDC guidelines  Patient qualified for home oxygen, 1 L via nasal cannula with activity  Patient agrees with plan of care
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Angiogram pulmonary abnormal, Anosmia, Anticoagulant therapy, Blood electrolytes normal
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 3/31/21 (lot not listed in database) COVID Positive 10/16/21  10/23/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days ago last Sunday.  He did receive the Johnson & Johnson vaccine several months ago.  He does have 1 sick contact approximately 2 weeks ago.  He has been symptomatic for 11 days.  He endorses worsening cough with activity, dyspnea on exertion, loss of taste and smell, fevers, and generalized muscle aches.  He has not taken anything other than DayQuil, NyQuil, Tylenol, and ibuprofen for pain and symptomatic relief.  He denies hemoptysis, chest pain, palpitations, changes to bowel or bladder function.   In the ED, patient was found to be saturating in the 90s on room air.  He did get up to walk and his saturations dropped to approximately 88. He was also slightly hypertensive to 157/108.  His respiratory rate was also slightly elevated in the 20s.  His lab workup was notable for an ESR of 25, a CRP 8.2, and a D-dimer of 0.92.  There was no leukocytosis or electrolyte abnormalities and troponin was negative at less than 0.01.  CT chest showed no evidence of pulmonary embolism.  There was scattered bilateral areas of airspace disease in all 5 lobes consistent with a viral pneumonia.  He received a DuoNeb treatment, azithromycin, Rocephin, and a dose of Solu-Medrol 125 mg. He was subsequently admitted to our service for management of COVID-19 infection.  10/26/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days prior to admission.  He did receive the Johnson Johnson vaccine several months ago.  At time of admission he had been symptomatic for 11 days.  In the ED, he was found to be hypoxic with walk test, he was started on supplemental oxygen.  D-dimer was 0.92, CTA chest showed no evidence of pulmonary embolism.  CT findings were consistent with viral pneumonia.  Due to need for supplemental oxygen patient was treated with remdesivir and dexamethasone.  Due to elevated D-dimer he was also started on prophylactic Lovenox daily.  Over the following 3 days patient's symptoms greatly improved, he was able to be weaned to room air and pass O2 walk test without difficulty.  He felt comfortable returning home.  He did not need further treatment with remdesivir dexamethasone, VTE risk factor score did not qualify him for home anticoagulation.  He was hypertensive throughout his hospitalization, he was started on losartan 25 mg. A1c was also noted to be 6.1, putting him in the pre diabetes range.  At time of discharge vitals were stable.  He is to follow-up with his PCP.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, Computerised tomogram thorax abnormal, Cough, Dyspnoea
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 3/31/21 (lot not listed in database) COVID Positive 10/16/21  10/23/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days ago last Sunday.  He did receive the Johnson & Johnson vaccine several months ago.  He does have 1 sick contact approximately 2 weeks ago.  He has been symptomatic for 11 days.  He endorses worsening cough with activity, dyspnea on exertion, loss of taste and smell, fevers, and generalized muscle aches.  He has not taken anything other than DayQuil, NyQuil, Tylenol, and ibuprofen for pain and symptomatic relief.  He denies hemoptysis, chest pain, palpitations, changes to bowel or bladder function.   In the ED, patient was found to be saturating in the 90s on room air.  He did get up to walk and his saturations dropped to approximately 88. He was also slightly hypertensive to 157/108.  His respiratory rate was also slightly elevated in the 20s.  His lab workup was notable for an ESR of 25, a CRP 8.2, and a D-dimer of 0.92.  There was no leukocytosis or electrolyte abnormalities and troponin was negative at less than 0.01.  CT chest showed no evidence of pulmonary embolism.  There was scattered bilateral areas of airspace disease in all 5 lobes consistent with a viral pneumonia.  He received a DuoNeb treatment, azithromycin, Rocephin, and a dose of Solu-Medrol 125 mg. He was subsequently admitted to our service for management of COVID-19 infection.  10/26/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days prior to admission.  He did receive the Johnson Johnson vaccine several months ago.  At time of admission he had been symptomatic for 11 days.  In the ED, he was found to be hypoxic with walk test, he was started on supplemental oxygen.  D-dimer was 0.92, CTA chest showed no evidence of pulmonary embolism.  CT findings were consistent with viral pneumonia.  Due to need for supplemental oxygen patient was treated with remdesivir and dexamethasone.  Due to elevated D-dimer he was also started on prophylactic Lovenox daily.  Over the following 3 days patient's symptoms greatly improved, he was able to be weaned to room air and pass O2 walk test without difficulty.  He felt comfortable returning home.  He did not need further treatment with remdesivir dexamethasone, VTE risk factor score did not qualify him for home anticoagulation.  He was hypertensive throughout his hospitalization, he was started on losartan 25 mg. A1c was also noted to be 6.1, putting him in the pre diabetes range.  At time of discharge vitals were stable.  He is to follow-up with his PCP.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Exposure to SARS-CoV-2, Fatigue, Fibrin D dimer increased, Glucose tolerance impaired
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 3/31/21 (lot not listed in database) COVID Positive 10/16/21  10/23/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days ago last Sunday.  He did receive the Johnson & Johnson vaccine several months ago.  He does have 1 sick contact approximately 2 weeks ago.  He has been symptomatic for 11 days.  He endorses worsening cough with activity, dyspnea on exertion, loss of taste and smell, fevers, and generalized muscle aches.  He has not taken anything other than DayQuil, NyQuil, Tylenol, and ibuprofen for pain and symptomatic relief.  He denies hemoptysis, chest pain, palpitations, changes to bowel or bladder function.   In the ED, patient was found to be saturating in the 90s on room air.  He did get up to walk and his saturations dropped to approximately 88. He was also slightly hypertensive to 157/108.  His respiratory rate was also slightly elevated in the 20s.  His lab workup was notable for an ESR of 25, a CRP 8.2, and a D-dimer of 0.92.  There was no leukocytosis or electrolyte abnormalities and troponin was negative at less than 0.01.  CT chest showed no evidence of pulmonary embolism.  There was scattered bilateral areas of airspace disease in all 5 lobes consistent with a viral pneumonia.  He received a DuoNeb treatment, azithromycin, Rocephin, and a dose of Solu-Medrol 125 mg. He was subsequently admitted to our service for management of COVID-19 infection.  10/26/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days prior to admission.  He did receive the Johnson Johnson vaccine several months ago.  At time of admission he had been symptomatic for 11 days.  In the ED, he was found to be hypoxic with walk test, he was started on supplemental oxygen.  D-dimer was 0.92, CTA chest showed no evidence of pulmonary embolism.  CT findings were consistent with viral pneumonia.  Due to need for supplemental oxygen patient was treated with remdesivir and dexamethasone.  Due to elevated D-dimer he was also started on prophylactic Lovenox daily.  Over the following 3 days patient's symptoms greatly improved, he was able to be weaned to room air and pass O2 walk test without difficulty.  He felt comfortable returning home.  He did not need further treatment with remdesivir dexamethasone, VTE risk factor score did not qualify him for home anticoagulation.  He was hypertensive throughout his hospitalization, he was started on losartan 25 mg. A1c was also noted to be 6.1, putting him in the pre diabetes range.  At time of discharge vitals were stable.  He is to follow-up with his PCP.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin increased, Hypertension, Hypoxia, Lung disorder, Myalgia
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 3/31/21 (lot not listed in database) COVID Positive 10/16/21  10/23/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days ago last Sunday.  He did receive the Johnson & Johnson vaccine several months ago.  He does have 1 sick contact approximately 2 weeks ago.  He has been symptomatic for 11 days.  He endorses worsening cough with activity, dyspnea on exertion, loss of taste and smell, fevers, and generalized muscle aches.  He has not taken anything other than DayQuil, NyQuil, Tylenol, and ibuprofen for pain and symptomatic relief.  He denies hemoptysis, chest pain, palpitations, changes to bowel or bladder function.   In the ED, patient was found to be saturating in the 90s on room air.  He did get up to walk and his saturations dropped to approximately 88. He was also slightly hypertensive to 157/108.  His respiratory rate was also slightly elevated in the 20s.  His lab workup was notable for an ESR of 25, a CRP 8.2, and a D-dimer of 0.92.  There was no leukocytosis or electrolyte abnormalities and troponin was negative at less than 0.01.  CT chest showed no evidence of pulmonary embolism.  There was scattered bilateral areas of airspace disease in all 5 lobes consistent with a viral pneumonia.  He received a DuoNeb treatment, azithromycin, Rocephin, and a dose of Solu-Medrol 125 mg. He was subsequently admitted to our service for management of COVID-19 infection.  10/26/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days prior to admission.  He did receive the Johnson Johnson vaccine several months ago.  At time of admission he had been symptomatic for 11 days.  In the ED, he was found to be hypoxic with walk test, he was started on supplemental oxygen.  D-dimer was 0.92, CTA chest showed no evidence of pulmonary embolism.  CT findings were consistent with viral pneumonia.  Due to need for supplemental oxygen patient was treated with remdesivir and dexamethasone.  Due to elevated D-dimer he was also started on prophylactic Lovenox daily.  Over the following 3 days patient's symptoms greatly improved, he was able to be weaned to room air and pass O2 walk test without difficulty.  He felt comfortable returning home.  He did not need further treatment with remdesivir dexamethasone, VTE risk factor score did not qualify him for home anticoagulation.  He was hypertensive throughout his hospitalization, he was started on losartan 25 mg. A1c was also noted to be 6.1, putting him in the pre diabetes range.  At time of discharge vitals were stable.  He is to follow-up with his PCP.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pain, Pneumonia viral, Pyrexia, Red blood cell sedimentation rate increased
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 3/31/21 (lot not listed in database) COVID Positive 10/16/21  10/23/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days ago last Sunday.  He did receive the Johnson & Johnson vaccine several months ago.  He does have 1 sick contact approximately 2 weeks ago.  He has been symptomatic for 11 days.  He endorses worsening cough with activity, dyspnea on exertion, loss of taste and smell, fevers, and generalized muscle aches.  He has not taken anything other than DayQuil, NyQuil, Tylenol, and ibuprofen for pain and symptomatic relief.  He denies hemoptysis, chest pain, palpitations, changes to bowel or bladder function.   In the ED, patient was found to be saturating in the 90s on room air.  He did get up to walk and his saturations dropped to approximately 88. He was also slightly hypertensive to 157/108.  His respiratory rate was also slightly elevated in the 20s.  His lab workup was notable for an ESR of 25, a CRP 8.2, and a D-dimer of 0.92.  There was no leukocytosis or electrolyte abnormalities and troponin was negative at less than 0.01.  CT chest showed no evidence of pulmonary embolism.  There was scattered bilateral areas of airspace disease in all 5 lobes consistent with a viral pneumonia.  He received a DuoNeb treatment, azithromycin, Rocephin, and a dose of Solu-Medrol 125 mg. He was subsequently admitted to our service for management of COVID-19 infection.  10/26/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days prior to admission.  He did receive the Johnson Johnson vaccine several months ago.  At time of admission he had been symptomatic for 11 days.  In the ED, he was found to be hypoxic with walk test, he was started on supplemental oxygen.  D-dimer was 0.92, CTA chest showed no evidence of pulmonary embolism.  CT findings were consistent with viral pneumonia.  Due to need for supplemental oxygen patient was treated with remdesivir and dexamethasone.  Due to elevated D-dimer he was also started on prophylactic Lovenox daily.  Over the following 3 days patient's symptoms greatly improved, he was able to be weaned to room air and pass O2 walk test without difficulty.  He felt comfortable returning home.  He did not need further treatment with remdesivir dexamethasone, VTE risk factor score did not qualify him for home anticoagulation.  He was hypertensive throughout his hospitalization, he was started on losartan 25 mg. A1c was also noted to be 6.1, putting him in the pre diabetes range.  At time of discharge vitals were stable.  He is to follow-up with his PCP.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory rate increased, SARS-CoV-2 test positive, Troponin normal, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 3/31/21 (lot not listed in database) COVID Positive 10/16/21  10/23/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days ago last Sunday.  He did receive the Johnson & Johnson vaccine several months ago.  He does have 1 sick contact approximately 2 weeks ago.  He has been symptomatic for 11 days.  He endorses worsening cough with activity, dyspnea on exertion, loss of taste and smell, fevers, and generalized muscle aches.  He has not taken anything other than DayQuil, NyQuil, Tylenol, and ibuprofen for pain and symptomatic relief.  He denies hemoptysis, chest pain, palpitations, changes to bowel or bladder function.   In the ED, patient was found to be saturating in the 90s on room air.  He did get up to walk and his saturations dropped to approximately 88. He was also slightly hypertensive to 157/108.  His respiratory rate was also slightly elevated in the 20s.  His lab workup was notable for an ESR of 25, a CRP 8.2, and a D-dimer of 0.92.  There was no leukocytosis or electrolyte abnormalities and troponin was negative at less than 0.01.  CT chest showed no evidence of pulmonary embolism.  There was scattered bilateral areas of airspace disease in all 5 lobes consistent with a viral pneumonia.  He received a DuoNeb treatment, azithromycin, Rocephin, and a dose of Solu-Medrol 125 mg. He was subsequently admitted to our service for management of COVID-19 infection.  10/26/21: Patient is a 52-year-old gentleman with history significant for gout who presented to the ED with worsening shortness of breath, cough, and fatigue for the last several days.  Patient tested positive for COVID-19 approximately 6 days prior to admission.  He did receive the Johnson Johnson vaccine several months ago.  At time of admission he had been symptomatic for 11 days.  In the ED, he was found to be hypoxic with walk test, he was started on supplemental oxygen.  D-dimer was 0.92, CTA chest showed no evidence of pulmonary embolism.  CT findings were consistent with viral pneumonia.  Due to need for supplemental oxygen patient was treated with remdesivir and dexamethasone.  Due to elevated D-dimer he was also started on prophylactic Lovenox daily.  Over the following 3 days patient's symptoms greatly improved, he was able to be weaned to room air and pass O2 walk test without difficulty.  He felt comfortable returning home.  He did not need further treatment with remdesivir dexamethasone, VTE risk factor score did not qualify him for home anticoagulation.  He was hypertensive throughout his hospitalization, he was started on losartan 25 mg. A1c was also noted to be 6.1, putting him in the pre diabetes range.  At time of discharge vitals were stable.  He is to follow-up with his PCP.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Blood disorder, Blood test, Computerised tomogram thorax, Condition aggravated, Feeling abnormal
Clinical narrative: CLIENT REPORTS HIVES AND INTENSE ITCHING AFTER LEAVING THE FACILITY. CLIENT ALSO REPORTED 2 DAYS ALTER (FRIDAY), THE CLIENT WENT INTO MEDICAL PROVIDER AFTER FEELING "WEIRD. CLIENT HAD BLOOD DRAWN AND WAS ALTER CALLED BACK TO THE HOSPITAL TO HAVE SCANS OF LUNGS TO EB SURE SHE DIDN'T HAVE BLOOD CLOTS. D-DIMER WAS HIGH (5 OR HIGHER). CLIENT REPORTED HAVING ISSUES WITH BLOOD FOR WEEKS AFTER.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Pruritus, Urticaria
Clinical narrative: CLIENT REPORTS HIVES AND INTENSE ITCHING AFTER LEAVING THE FACILITY. CLIENT ALSO REPORTED 2 DAYS ALTER (FRIDAY), THE CLIENT WENT INTO MEDICAL PROVIDER AFTER FEELING "WEIRD. CLIENT HAD BLOOD DRAWN AND WAS ALTER CALLED BACK TO THE HOSPITAL TO HAVE SCANS OF LUNGS TO EB SURE SHE DIDN'T HAVE BLOOD CLOTS. D-DIMER WAS HIGH (5 OR HIGHER). CLIENT REPORTED HAVING ISSUES WITH BLOOD FOR WEEKS AFTER.
Age: 67.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Headache, Pain in extremity
Clinical narrative: A few hours after the vaccine, I had a serious, chronic headache and soreness in my arms. I saw the doctor the following day and received Butol for the headache. It helped with the headache. The doctor thinks it was probably due to flu and COVID-19 vaccine on same day.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: per death certificate, Patient died in the rehab center after a hospitalization for COVID positive test; treated with dexamethasone, ABX, O2 supplementation; sent back to Rehab Center where she later passed away.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was hospitalized with COVID after receiving COVID vaccine.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Hypoaesthesia, Impaired work ability, Mobility decreased, Pain
Clinical narrative: Received vaccine on 3/14/22. On 3/15/22, I noticed pain in my right arm radiating to my mid back and assumed it would go away. The next morning, I woke up and couldn't move my arm due to extreme pain. I went to the doctor and was prescribed a muscle relaxer and told to take ibuprofen and tylenol. I tried this with no relief. On 3/18/22, I started having numbness in my fingers and increased pain so I went to the ED. I was prescribed pain medication and started a prednisone taper. The pain and numbness have not subsided. I am unable to work and followed up with my doctor on 3/22/22. I have been placed on a medical leave since I can't perform my duties as a registered nurse,
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Received vaccine on 3/14/22. On 3/15/22, I noticed pain in my right arm radiating to my mid back and assumed it would go away. The next morning, I woke up and couldn't move my arm due to extreme pain. I went to the doctor and was prescribed a muscle relaxer and told to take ibuprofen and tylenol. I tried this with no relief. On 3/18/22, I started having numbness in my fingers and increased pain so I went to the ED. I was prescribed pain medication and started a prednisone taper. The pain and numbness have not subsided. I am unable to work and followed up with my doctor on 3/22/22. I have been placed on a medical leave since I can't perform my duties as a registered nurse,
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse events.  Medication error - Patient was given an additional booster dose when not eligible.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was hospitalized with COVID after receiving COVID vaccine.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness unilateral, Laboratory test abnormal, Macular degeneration, Ophthalmological examination abnormal, Vision blurred
Clinical narrative: I had my 2nd Covid shot on March 13, 2021. I waited my 15 minutes then headed home. Thank goodness my husband was driving because my eyes wouldn't stay focused on anything. They just kept jumping from one thing to another all evening. The next day I noticed I wasn't seeing like I should. It was like part of my vision was missing out of my left eye.  I decided to see an eye doctor ad they sent me to a retina specialist.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Myelitis, Paraesthesia
Clinical narrative: Patient reported numbness and tingling of her extremities 4 days following vaccination.  Patient was ultimately diagnosed with cervical myelitis
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was hospitalized with COVID after receiving COVID vaccine.
Age: 80.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Condition aggravated, Nausea, Oropharyngeal pain, Productive cough
Clinical narrative: Sore throat at 6PM, worse overnight. Nausea next day 8AM, Cough (productive ) 3PM lasting for two weeks plus. Weakness 8AM also next day, continuing for two weeks plus.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Magnetic resonance imaging, Rheumatoid arthritis, X-ray
Clinical narrative: diagnosed with Rheumatoid Arthritis after Moderna vaccine
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Medication error, No adverse event
Clinical narrative: No adverse events.  -Med error - administered additional booster dose when not eligible
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was hospitalized with COVID after receiving COVID vaccine.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cardiac arrest, Cough
Clinical narrative: pt had a positive home COVID test on 1/5/22; was seen in ED on 1/11/22 for SOB, given oral steroids and home O2 and dc'd to home; back to ED on 1/20/22 with cough and increasing SOB; O2 sat 85% on 6L O2 via NC in ED; increased O2 supplementation and admitted pt; PE found in left lung; ARF with hypoxia; COVID pneumonia; critically ill; given COVID direct therapy; pt experienced a PEA cardiac arrest, code was run, but pt expired in the hospital
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Critical illness, Death, Dyspnoea, Pulseless electrical activity, SARS-CoV-2 test positive
Clinical narrative: pt had a positive home COVID test on 1/5/22; was seen in ED on 1/11/22 for SOB, given oral steroids and home O2 and dc'd to home; back to ED on 1/20/22 with cough and increasing SOB; O2 sat 85% on 6L O2 via NC in ED; increased O2 supplementation and admitted pt; PE found in left lung; ARF with hypoxia; COVID pneumonia; critically ill; given COVID direct therapy; pt experienced a PEA cardiac arrest, code was run, but pt expired in the hospital
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was hospitalized with COVID after receiving a COVID vaccine.
Age: 68.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Chills, Fatigue, Injection site pain, Movement disorder, Pyrexia
Clinical narrative: pt states she was in the bed and started shivering so bad she could not move.  She had fatigue and developed a fever.  She also had loose bowels which lasted for about 3 days.   A week later she developed a red rash on her right leg and right buttock.  She applied Neosporin ointment. She still has pain in the right arm at the injection site.
Age: 68.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Rash, Rash erythematous
Clinical narrative: pt states she was in the bed and started shivering so bad she could not move.  She had fatigue and developed a fever.  She also had loose bowels which lasted for about 3 days.   A week later she developed a red rash on her right leg and right buttock.  She applied Neosporin ointment. She still has pain in the right arm at the injection site.
Age: 42.0
Sex: F
Vaccine: IPV, MNQ
Symptoms: Lip pruritus, Lip swelling, Nodule, Pain in extremity, Rash
Clinical narrative: On 3/17  Patient reports rash soreness and lump to right arm.  Also reports itchy to left lip and swelling.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was hospitalized with COVID after receiving COVID vaccine.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Feeling abnormal, Headache
Clinical narrative: I woke up with a very sore throat and a lot of congestion. It took until that evening until I took a at home COVID test which came back positive. I was coughing continuously for 3-5 minutes intermittently. My pulse ox reading was dipping to 95% when I coughed, it was up to 120% most of the time. Headache and nausea and a lot of fatigue. For the past week I've mainly been sleeping and taking Tylenol to keep the low grade fever down and monitoring my oxygen and heart rate. Now it's just slight brain fog and fatigue, I no longer have a fever or congested.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Nausea, Oropharyngeal pain, Pyrexia, Respiratory tract congestion
Clinical narrative: I woke up with a very sore throat and a lot of congestion. It took until that evening until I took a at home COVID test which came back positive. I was coughing continuously for 3-5 minutes intermittently. My pulse ox reading was dipping to 95% when I coughed, it was up to 120% most of the time. Headache and nausea and a lot of fatigue. For the past week I've mainly been sleeping and taking Tylenol to keep the low grade fever down and monitoring my oxygen and heart rate. Now it's just slight brain fog and fatigue, I no longer have a fever or congested.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I woke up with a very sore throat and a lot of congestion. It took until that evening until I took a at home COVID test which came back positive. I was coughing continuously for 3-5 minutes intermittently. My pulse ox reading was dipping to 95% when I coughed, it was up to 120% most of the time. Headache and nausea and a lot of fatigue. For the past week I've mainly been sleeping and taking Tylenol to keep the low grade fever down and monitoring my oxygen and heart rate. Now it's just slight brain fog and fatigue, I no longer have a fever or congested.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Mobility decreased, Neck mass, Pain
Clinical narrative: Patient states a week after the shot she developed a painful lump near her shoulder under her neck. The pain worsened over time and moved to the under side of her armpit. Patient states she is unable to lift her arm due to severe pain even now 6 months after the shot. She has seen multiple doctors and has not received a proper diagnosis but all doctors are stating this is due to the moderna shot (per patient report)
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arrhythmia, Blood pressure increased, Dyspnoea
Clinical narrative: I began to have difficulty breathing, my pressure went up and I felt arrhythmias, the symptoms began to decrease around 1 am after I took medicine to calm the pressure
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was hospitalized with COVID after receiving COVID vaccine.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Fatigue, Malaise
Clinical narrative: On 11/20/2021, I began to feel ill. I had a stuffy nose. On 11/21/2021, I still had a stuffy nose and also felt fatigued. I lost my sense of smell, and it was then that I decided to take an at-home test for COVID-19. The result was positive, so I had a breakthrough case. I also went on to lose my sense of taste. The loss of sense of taste lasted for 8 days, and the loss of sense of smell lasted for 7. I felt so fatigued that I spent a great deal of time sleeping. However, I never had a cough or fever.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, SARS-CoV-2 test positive, Somnolence
Clinical narrative: On 11/20/2021, I began to feel ill. I had a stuffy nose. On 11/21/2021, I still had a stuffy nose and also felt fatigued. I lost my sense of smell, and it was then that I decided to take an at-home test for COVID-19. The result was positive, so I had a breakthrough case. I also went on to lose my sense of taste. The loss of sense of taste lasted for 8 days, and the loss of sense of smell lasted for 7. I felt so fatigued that I spent a great deal of time sleeping. However, I never had a cough or fever.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Guillain-Barre syndrome, Headache, Infectious mononucleosis, Mononucleosis heterophile test positive
Clinical narrative: Headache, fatigue progression of symptoms to severe fatigue, throat discomfort, low grade fever, oral sores, croup like coughing. Diagnosed with Guillane Barre and active mono.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oropharyngeal discomfort, Productive cough, Pyrexia, Stomatitis
Clinical narrative: Headache, fatigue progression of symptoms to severe fatigue, throat discomfort, low grade fever, oral sores, croup like coughing. Diagnosed with Guillane Barre and active mono.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Hyperhidrosis, Pain, Pain in extremity, Ultrasound Doppler
Clinical narrative: swaeting, bodyaches, forearm pain
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Cough, Nausea, Pyrexia
Clinical narrative: I experienced memory loss, fever, coughing and nausea.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: CLIENT PRESENTED FOR HER SECOND DOSE WITH CLAIMS THAT SHE RECEIVED A PFIZER VACCINE FOR HER FIRST DOSE. STATE REGISTRY INDICATES FIRST DOSE WAS MODERNA ENTERED BY PHARMACY ON 9/14/2021 WITH MODERNA LOT #.   MODERNA VACCINE NOT AVAILABLE AT THIS MASS VACCINATION SITE. PFIZER VACCINE ADMINISTERED AS CLIENT'S SECOND DOSE OVER 28 DAYS LATER ON 10/22/2021.  NOT SURE IF THIS COUNTS AS AN ADMINISTRATION ERROR OR NOT SINCE IT IS UNKNOWN IF CLIENT COULD HAVE DRIVEN SOMEWHERE ELSE TO OBTAIN MODERNA VACCINE TO MATCH HER FIRST DOSE IN SERIES.  ASSUMING SHE COULD NOT, THEN MIXING MANUFACTURERS IN PRIMARY SERIES IS ACCEPTED ALTHOUGH NOT PREFERRED OR RECOMMENDED.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I got COVID after Dose 3 got tested on March 8, 2022. I experienced burning on the back of the throat and a intermediate cough (described as a tingling cough), no fever, no difficulty breathing and symptoms lasted to Sunday March 13, 2022.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Pruritus, Sensitive skin, Urticaria
Clinical narrative: On April 3,2021, dose 1 of the vaccine after couple of hours I started itching. It progressed over during the night. It started looking like hives. The hospital didn't know what to do with me. It started at 6:30PM. I can't even wear any kind of clothes at all. It itched severely. I only wore clothes to go to see my doctor. My doctor gave me medication which are Atarax 10mg every six hours 1-4 tablets, I was taking Claritin which really saved my life. 10 days to 2 weeks, my discomfort stopped but it all depended on the medication I was taking.